PHASE-I AND PHARMACOLOGICAL STUDY OF TOPOTECAN - A NOVEL TOPOISOMERASE-I INHIBITOR

被引：346
作者：
ROWINSKY, EK
GROCHOW, LB
HENDRICKS, CB
ETTINGER, DS
FORASTIERE, AA
HUROWITZ, LA
MCGUIRE, WP
SARTORIUS, SE
LUBEJKO, BG
KAUFMANN, SH
DONEHOWER, RC
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1992年 / 10卷 / 04期
关键词：
D O I：
10.1200/JCO.1992.10.4.647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：647 / 656
页数：10
相关论文
共 32 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE NEW ANTITUMOR DRUG SK-AND-F 104864-A (NSC 609699) IN PLASMA [J].
BEIJNEN, JH ;
SMITH, BR ;
KEIJER, WJ ;
VANGIJN, R ;
HUININK, WWT ;
VLASVELD, LT ;
RODENHUIS, S ;
UNDERBERG, WJM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1990, 8 (8-12) :789-794
[2]  
CREAVEN PJ, 1972, CANCER CHEMOTH REP 1, V56, P573
[3]   TOPOISOMERASE-TARGETING ANTITUMOR DRUGS [J].
DARPA, P ;
LIU, LF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 989 (02) :163-177
[4]   DNA TOPOISOMERASES FROM RAT-LIVER - PHYSIOLOGICAL VARIATIONS [J].
DUGUET, M ;
LAVENOT, C ;
HARPER, F ;
MIRAMBEAU, G ;
DERECONDO, AM .
NUCLEIC ACIDS RESEARCH, 1983, 11 (04) :1059-1075
[5]  
ENG WK, 1988, MOL PHARMACOL, V34, P755
[6]   DNA TOPOISOMERASE-I TARGETED CHEMOTHERAPY OF HUMAN-COLON CANCER IN XENOGRAFTS [J].
GIOVANELLA, BC ;
STEHLIN, JS ;
WALL, ME ;
WANI, MC ;
NICHOLAS, AW ;
LIU, LF ;
SILBER, R ;
POTMESIL, M .
SCIENCE, 1989, 246 (4933) :1046-1048
[7]  
GOLDSTEIN A, 1974, PRINCIPLES DRUG ACTI, P83
[8]   EXPRESSION OF A MULTIDRUG RESISTANCE GENE IN HUMAN CANCERS [J].
GOLDSTEIN, LJ ;
GALSKI, H ;
FOJO, A ;
WILLINGHAM, M ;
LAI, SL ;
GAZDAR, A ;
PIRKER, R ;
GREEN, A ;
CRIST, W ;
BRODEUR, GM ;
LIEBER, M ;
COSSMAN, J ;
GOTTESMAN, MM ;
PASTAN, I .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) :116-124
[9]  
GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461
[10]  
GOTTLIEB JA, 1972, CANCER CHEMOTH REP 1, V56, P103
1234